Hammersmith Medicines Research Limited
Hammersmith Medicines Research Limited is an active company incorporated on 15 January 1993 with the registered office located in London, Greater London. Hammersmith Medicines Research Limited was registered 32 years ago.
Status
Active
Active since incorporation
Company No
02779946
Private limited company
Age
32 years
Incorporated 15 January 1993
Size
Medium
Turnover is under £54M
Balance sheet is under £27M
Confirmation
Submitted
Dated 15 January 2025 (9 months ago)
Next confirmation dated 15 January 2026
Due by 29 January 2026 (2 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Feb ⟶ 31 Jan 2024 (12 months)
Accounts type is Group
Next accounts for period 31 July 2025
Due by 30 April 2026 (5 months remaining)
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Charles Kevin O'Brien and Dr Malcolm James Boyce are mutual people.
Active
Charles Kevin O'Brien and Dr Malcolm James Boyce are mutual people.
Active
Dr Malcolm James Boyce is a mutual person.
Active
Brands
Hammersmith Medicines Research Ltd is a Clinical Research Organisation (CRO) that focuses on early phase clinical trials for pharmaceutical and biotechnology companies.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Jan 2024
For period 31 Jan ⟶ 31 Jan 2024
Traded for 12 months
Cash in Bank
£3.74M
Increased by £1.75M (+88%)
Turnover
£21.48M
Increased by £862K (+4%)
Employees
291
Decreased by 17 (-6%)
Total Assets
£28.37M
Decreased by £688K (-2%)
Total Liabilities
-£4.71M
Increased by £42K (+1%)
Net Assets
£23.66M
Decreased by £730K (-3%)
Debt Ratio (%)
17%
Increased by 0.54% (+3%)
Get Credit Report
Discover Hammersmith Medicines Research Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
